HomeCompareEKTAF vs JEPI

EKTAF vs JEPI: Dividend Comparison 2026

EKTAF yields 4.14% · JEPI yields 8.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EKTAF wins by $60.1K in total portfolio value· pulled ahead in Year 2
10 years
EKTAF
EKTAF
● Live price
4.14%
Share price
$6.20
Annual div
$0.26
5Y div CAGR
33.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$89.0K
Annual income
$24,064.33
Full EKTAF calculator →
JEPI
JPMorgan Equity Premium Income ETF
● Live price
8.40%
Share price
$56.68
Annual div
$4.76
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.0K
Annual income
$1,528.62
Full JEPI calculator →

Portfolio growth — EKTAF vs JEPI

📍 EKTAF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEKTAFJEPI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EKTAF + JEPI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EKTAF pays
JEPI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EKTAF
Annual income on $10K today (after 15% tax)
$352.23/yr
After 10yr DRIP, annual income (after tax)
$20,454.68/yr
JEPI
Annual income on $10K today (after 15% tax)
$714.16/yr
After 10yr DRIP, annual income (after tax)
$1,299.33/yr
At 15% tax rate, EKTAF beats the other by $19,155.35/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EKTAF + JEPI for your $10,000?

EKTAF: 50%JEPI: 50%
100% JEPI50/50100% EKTAF
Portfolio after 10yr
$59.0K
Annual income
$12,796.47/yr
Blended yield
21.68%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EKTAF buys
0
JEPI buys
0
No recent congressional trades found for EKTAF or JEPI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEKTAFJEPI
Forward yield4.14%8.40%
Annual dividend / share$0.26$4.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR33.2%0%
Portfolio after 10y$89.0K$29.0K
Annual income after 10y$24,064.33$1,528.62
Total dividends collected$61.5K$11.7K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: EKTAF vs JEPI ($10,000, DRIP)

YearEKTAF PortfolioEKTAF Income/yrJEPI PortfolioJEPI Income/yrGap
1$11,252$551.96$11,260$840.19$8.00JEPI
2← crossover$12,813$773.14$12,641$907.94+$172.00EKTAF
3$14,806$1,095.96$14,150$978.20+$656.00EKTAF
4$17,418$1,576.51$15,795$1,050.85+$1.6KEKTAF
5$20,947$2,308.89$17,584$1,125.74+$3.4KEKTAF
6$25,869$3,456.43$19,526$1,202.74+$6.3KEKTAF
7$32,994$5,313.97$21,628$1,281.69+$11.4KEKTAF
8$43,741$8,437.06$23,898$1,362.43+$19.8KEKTAF
9$60,727$13,923.91$26,347$1,444.79+$34.4KEKTAF
10$89,042$24,064.33$28,982$1,528.62+$60.1KEKTAF

EKTAF vs JEPI: Complete Analysis 2026

EKTAFStock

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Full EKTAF Calculator →

JEPIETF

The fund seeks to provide the majority of the returns associated with its primary benchmark, the Standard & Poor's 500 Total Return Index (S&P 500 Index), while exposing investors to less risk through lower volatility and still offering incremental income. Under normal circumstances, the fund invests at least 80% of its assets in equity securities. It may also invest in other equity securities not included in the S&P 500 Index.

Full JEPI Calculator →
📬

Get this EKTAF vs JEPI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EKTAF vs SCHDEKTAF vs OEKTAF vs KOEKTAF vs MAINEKTAF vs JEPQEKTAF vs XYLDEKTAF vs DIVOEKTAF vs QYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.